ArticleCell genomics2026
Genomic and socioeconomic drivers of antimicrobial resistance forecast to 2050.
Article in Cell genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance (AMR) is rising worldwide, and a better understanding of the genetic and socioeconomic determinants tied to it may establish a vantage point for surveillance and intervention. Unfortunately, the interactions between antibiotics, pathogens, and their environments are complex and deeply intertwined. Here, we present a novel machine learning and forecasting approach, integrating genomics, antibiotic phenotyping, and socioeconomic and environmental variables, designed to uncover hidden correlations and trends. Through the analysis of 45,616 bacterial genomes from 16 pathogens, 298,178 resistance profiles, and 1,112 social, economic, and environmental indicators collected across 127 countries, we identified 210 pathogen-specific AMR traits projected to increase by 2050, together with the key indicators associated with these trends. These traits were identified using structure-aware mixed-effects models with cluster-grouped cross-validation, controlling for lineage dependence. The 32 most critical rising traits were strongly linked to indicators of socioeconomic disparity. These findings provide a roadmap for targeted AMR interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.